UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Budesonide Extended-Release in Patients With Mild to Moderate Ulcerative Colitis

Gastroenterology & hepatology, 2015-01, Vol.11 (1), p.56-58

Kornbluth, Asher

2015

Volltextzugriff (PDF)

Mucosal Healing in Inflammatory Bowel Disease: Where Do We Stand?

Current gastroenterology reports, 2010-12, Vol.12 (6), p.471-478

2010

Volltextzugriff (PDF)

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Gut, 2014-01, Vol.63 (1), p.88-95

2014

Volltextzugriff (PDF)

Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis

The American journal of gastroenterology, 2017-11, Vol.112 (11), p.1719-1721

2017

Volltextzugriff (PDF)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Gastroenterology (New York, N.Y. 1943), 2022-02, Vol.162 (3), p.S104-S105

2022

Volltextzugriff (PDF)

Vedolizumab as a Treatment for Crohn's Disease and Ulcerative Colitis

Gastroenterology & hepatology, 2014-12, Vol.10 (12), p.793-800

2014

Volltextzugriff (PDF)

A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business

Inflammatory bowel diseases, 2016-10, Vol.22 (10), p.2513-2526

2016

Volltextzugriff (PDF)

Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

Gastroenterology & hepatology, 2022-03, Vol.18 (3), p.145-155

2022

Volltextzugriff (PDF)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Inflammatory bowel diseases, 2022-01, Vol.28 (Supplement_1), p.S104-S105

2022

Volltextzugriff (PDF)

Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies

Gastroenterology (New York, N.Y. 1943), 2021-03, Vol.160 (4), p.1118-1130.e3

2021

Volltextzugriff (PDF)

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-599-S-599

2022

Volltextzugriff (PDF)

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Inflammatory bowel diseases, 2011-02, Vol.17 (2), p.599-604

2011

Volltextzugriff (PDF)

Cyclosporine versus infliximab for the treatment of severe ulcerative colitis

Gastroenterology & hepatology, 2011-10, Vol.7 (10), p.677-679

Kornbluth, Asher

2011

Volltextzugriff (PDF)

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Gut, 2012-04, Vol.61 (4), p.535-542

2012

Volltextzugriff (PDF)

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry

Inflammatory bowel diseases, 2022-07, Vol.28 (7), p.1126-1129

2022

Volltextzugriff (PDF)

Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

Clinical gastroenterology and hepatology, 2008-10, Vol.6 (10), p.1112-1116

2008

Volltextzugriff (PDF)

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Gastroenterology (New York, N.Y. 1943), 2013-11, Vol.145 (5), p.978-986.e5

2013

Volltextzugriff (PDF)

Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease

Clinical gastroenterology and hepatology, 2015-03, Vol.13 (3), p.539-547.e2

2015

Volltextzugriff (PDF)

Delayed-Release Oral Mesalamine at 4.8 g day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial

The American journal of gastroenterology, 2005-11, Vol.100 (11), p.2478-2485

2005

Volltextzugriff (PDF)

The Rising Epidemic of Obesity in Patients with Inflammatory Bowel Disease

Current treatment options in gastroenterology, 2024-06, Vol.22 (3), p.134-144

2024

Volltextzugriff (PDF)

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease

Expert review of gastroenterology & hepatology, 2015-04, Vol.9 (4), p.497-505

2015

Volltextzugriff (PDF)

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

The New England journal of medicine, 1994-06, Vol.330 (26), p.1841-1845

1994

Volltextzugriff (PDF)

Endoscopic management of intestinal strictures in Crohn's disease: Commentary

Inflammatory bowel diseases, 2007-03, Vol.13 (3), p.362-363

Kornbluth, Asher

2007

Volltextzugriff (PDF)

Video capsule endoscopy in inflammatory bowel disease: Past, present, and future redux

Inflammatory bowel diseases, 2010-07, Vol.16 (7), p.1254-1262

2010

Volltextzugriff (PDF)

26 – 50 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(137)
Buchkapitel
(2)

Sprache

Englisch
(139)

Erscheinungsjahr

n.n

Thema

Humans
(66)
Life Sciences & Biomedicine
(63)
Science & Technology
(63)
Gastroenterology & Hepatology
(58)
Female
(32)
Male
(30)
Adult
(29)
Gastroenterology
(25)
Gastroenterology And Hepatology
(24)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Inflammatory Bowel Disease
(20)
Middle Aged
(20)
Crohn's Disease
(19)
Ulcerative Colitis
(18)
Gastroenterology. Liver. Pancreas. Abdomen
(16)
Other Diseases. Semiology
(16)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(16)
Treatment Outcome
(16)
Crohn Disease - Drug Therapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Budesonide Extended-Release in Patients With Mild to Moderate Ulcerative Colitis

Mucosal Healing in Inflammatory Bowel Disease: Where Do We Stand?

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Vedolizumab as a Treatment for Crohn's Disease and Ulcerative Colitis

A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business

Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Cyclosporine versus infliximab for the treatment of severe ulcerative colitis

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry

Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Factors Associated With Short- and Long-Term Outcomes of Therapy for Crohn’s Disease

Delayed-Release Oral Mesalamine at 4.8 g day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial

The Rising Epidemic of Obesity in Patients with Inflammatory Bowel Disease

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

Endoscopic management of intestinal strictures in Crohn's disease: Commentary

Video capsule endoscopy in inflammatory bowel disease: Past, present, and future redux

Suchergebnisse filtern